Applied DNA Sciences (Applied DNA Sciences) Cash per Share : $3.65 (As of Mar. 2024)

View and export this data going back to 2001. Start your Free Trial

What is Applied DNA Sciences Cash per Share?

Cash per Share is calculated as Cash, Cash Equivalents, Marketable Securities divided by Shares Outstanding (EOP). Applied DNA Sciences's Cash per Share for the quarter that ended in Mar. 2024 was $3.65.

Applied DNA Sciences Cash per Share Historical Data

The historical data trend for Applied DNA Sciences's Cash per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Applied DNA Sciences Cash per Share Chart

Applied DNA Sciences Annual Data

Trend

Sep14

Sep15

Sep16

Sep17

Sep18

Sep19

Sep20

Sep21

Sep22

Sep23

Cash per Share

Get a 7-Day Free Trial

9.31

30.28

17.51

23.57

10.47

Applied DNA Sciences Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Cash per Share	Get a 7-Day Free Trial															19.04	16.67	10.47	4.90	3.65

Applied DNA Sciences Cash per Share Calculation

This is the ratio of a company's available cash, including easy to liquidate short-term investment, to its total number of shares outstanding. The result indicates the percentage of a company's share price that is available to spend on company's activities, such as strengthening the business, paying down the debt and making dividend payment to shareholders. It's a reliable indicator of a company's financial health.

Applied DNA Sciences's Cash per Share for the fiscal year that ended in Sep. 2023 is calculated as:

Cash per Share	=	Cash, Cash Equivalents, Marketable Securities	/	Shares Outstanding (EOP)
	=	7.152	/	0.68
	=	10.47

Applied DNA Sciences's Cash per Share for the quarter that ended in Mar. 2024 is calculated as:

Cash per Share	=	Cash, Cash Equivalents, Marketable Securities	/	Shares Outstanding (EOP)
	=	3.15	/	0.86
	=	3.65

Applied DNA Sciences (NAS:APDN) Cash per Share Explanation

Cash per Share represents the liquidity of a compant's assets. A high level of Cash per Share suggests that there's enough money on hand for a company to cover any emergencies and that the company has adequate money to reinvest its business or pay dividends to investors. However, if the ratio is too high, it can also suggeust the inefficiency of management for not making a full usage of the cash.

Applied DNA Sciences Cash per Share Related Terms

Thank you for viewing the detailed overview of Applied DNA Sciences's Cash per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

Applied DNA Sciences (Applied DNA Sciences) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Applied DNA Sciences Inc (NAS:APDN) » Definitions » Cash per Share

Comparable Companies

Traded in Other Exchanges

UDJP:Germany

Address

50 Health Sciences Drive, Stony Brook, New York, NY, USA, 11790

Website

https://www.adnas.com

Applied DNA Sciences Inc is a biotechnology company developing and commercializing technologies to produce and detect deoxyribonucleic acid (DNA) nd ribonucleic acid (RNA). The company operates in three business segments- Therapeutic DNA Production Services, MDx Testing Services, and DNA Tagging and Security Products and Services. It generates majority of its revenue from the MDx Testing Services which is involved in performing and developing clinical molecular diagnostic and genetic tests and clinical laboratory testing services. The company provides its products and services under the brand of Applied DNA Sciences, SigNature molecular tags, SigNature T molecular tags, fiberTyping, SigNify and others.

Executives

Clay Shorrock	officer: Chief Legal Officer	C/O APPLIED DNA SCIENCES, INC., 50 HEALTH SCIENCES DRIVE, STONY BROOK NY 11790
Scott L Anchin	director	16990 GOLDENTOP ROAD, SUITE A, SAN DIEGO CA 92127
William W Montgomery	10 percent owner	34211 SEAVEY LOOP RD., EUGENE OR 97405
Judith Murrah	officer: Chief Information Officer	C/O APPLIED DNA SCIENCES, INC., 50 HEALTH SCIENCES DRIVE, STONY BROOK NY 11790
Beth Jantzen	officer: Chief Financial Officer	C/O APPLIED DNA SCIENCES, INC., 50 HEALTH SCIENCES DRIVE, STONY BROOK NY 11790
Yacov A Shamash	director
Robert B Catell	director	62 OSBORNE ROAD, GARDEN CITY NY 11530
John Iii Bitzer	director	C/O APPLIED DNA SCIENCES, INC., 50 HEALTH SCIENCES DRIVE, STONY BROOK NY 11790
Joseph D. Ceccoli	director	C/O APPLIED DNA SCIENCES, INC., 50 HEALTH SCIENCES DRIVE, STONY BROOK NY 11790
Elizabeth M. Ferguson	director	50 HEALTH SCIENCES DRIVE, STONY BROOK NY 11790
Charles S. Ryan	director	C/O APPLIED DNA SCIENCES, INC., 50 HEALTH SCIENCES DRIVE, STONY BROOK NY 11790
James A Hayward	director, officer: Chief Executive Officer	C/O 25 HEALTH SCIENCES DRIVE, SUITE 113, NEW YORK NY 11790
Karol Gray	officer: Chief Financial Officer	C/O APPLIED DNA SCIENCES, INC., 50 HEALTH SCIENCES DRIVE, STONY BROOK NY 11790
Ming-hwa Benjamin Liang	officer: Strategic Tech. Dev. Officer	C/O APPLIED DNA SCIENCES, INC., 50 HEALTH SCIENCES DRIVE, STONY BROOK NY 11790
Yacov Shamash	director	100 ENGINEERING, STATE UNIVERSITY OF NY, STONE BROOK NY 117942200